(Q54327172)

27 May 2018

title

A blinded, randomized, placebo-controlled trial to compare theophylline and doxapram for the treatment of apnea of prematurity. (English)

1 reference

27 May 2018

1 reference

placebo-controlled trial

1 reference

Peliowski A

1

1 reference

27 May 2018

Finer NN

series ordinal

2

1 reference

27 May 2018

language of work or name

English

0 references

publication date

1 April 1990

1 reference

27 May 2018

The Journal of Pediatrics

published in

1 reference

27 May 2018

volume

116

1 reference

27 May 2018

page(s)

648-653

1 reference

27 May 2018

issue

4

1 reference

27 May 2018

Apnoeic attacks in the newborn treated with aminophylline

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2981620-8

Efficacy of caffeine in treatment of apnea in the low-birth-weight infant

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2981620-8

Doxapram in the treatment of idiopathic apnea of prematurity unresponsive to aminophylline

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2981620-8

Physiologic effects of doxapram in idiopathic apnea of prematurity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2981620-8

The dose response of theophylline in the treatment of apnea of prematurity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2981620-8

Idiopathic apnoea of prematurity treated with doxapram and aminophylline

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2981620-8

Doxapram dosage regimen in apnea of prematurity based on pharmacokinetic data

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2981620-8

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0022-3476(05)81620-8

1 reference

27 May 2018

PubMed ID

2181103

1 reference

27 May 2018